Related Experiment Video
Updated: Jan 10, 2026

08:53
Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
Published on: May 16, 2017
9.1K
A Complex FGF14 (TTC)/(TGC) Repeat Expansion in Parkinson's Disease
Xiaosheng Zheng1,2, Zhidong Cen1, Xinhui Chen1
1Department of Neurology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, China.
Movement Disorders : Official Journal of the Movement Disorder Society
|November 24, 2025
Summary
A novel complex repeat expansion in the FGF14 gene is identified as a genetic risk factor for Parkinson's disease (PD) in the Asian population. This finding highlights FGF14 repeat expansions as a potential contributor to PD pathogenesis.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Repeat expansions are known genetic risk factors for Parkinson's disease (PD).
- The FGF14-SCA27B (GAA)•(TTC) repeat locus, a novel repeat expansion site, remained unexplored in PD research.
- Investigating novel genetic loci is crucial for understanding PD etiology.
Purpose of the Study:
- To investigate the role of FGF14 repeat expansions as a potential genetic risk factor for Parkinson's disease (PD) in the Asian population.
- To characterize the sequence composition and genotypic patterns of FGF14 repeat expansions.
- To determine the association between FGF14 repeat expansions and PD risk through case-control studies.
Main Methods:
- Genetic sequencing and polymerase chain reaction (PCR) techniques were employed to detect pure and complex repeat expansions in the FGF14 gene in Asian PD patients.
- Targeted long-read sequencing was utilized to analyze the detailed sequence composition of identified repeat expansions.
- Case-control studies were conducted to assess the association between FGF14 repeat expansions and PD risk.
Main Results:
- A pure (TTC)≥250 repeat expansion was found in 0.17% of PD patients.
- A complex (TTC)/(TGC)≥300 repeat expansion, with four distinct segments and genotypic patterns, was identified as the main expanded genotype.
- Pattern 4 of the complex (TTC)/(TGC) repeat expansion showed significant enrichment in PD patients compared to controls, confirmed across discovery, replication, and meta-analysis cohorts (P=0.015, OR=1.75).
Conclusions:
- A unique complex (TTC)/(TGC) repeat expansion in the FGF14 gene represents a novel genetic risk factor for Parkinson's disease (PD) in the Asian population.
- This discovery expands the known genetic landscape of PD and implicates FGF14 in its pathogenesis.
- Further research into FGF14 repeat expansions may offer new diagnostic and therapeutic avenues for PD.
Related Concept Videos
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953

